Key Takeaways Tema Oncology ETF (CANC) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has surged 72.8% from its 52-week low price of $26.24 per share. CANC in Focus The Tema Oncology ETF seeks to provide long-term growth by investing in companies operating in the oncology industry. The CANC ETF consists of 58 total holdings, with the top 10 constituting 40.20% of the fund's assets. The leading holdings include Revolution Medicines Inc (6.02%), Eli Lilly & Co (5 ...